Cardiac ultrasound technology has advanced to keep up with several trends. These include improved workflow for greater efficiency, expanded use of qualification metrics, expanded use of 3-D echo to speed exam times and improve operator reproducibility, and expanded use of 3-D transesophageal echo (TEE) to aid guidance in the growing area of transcatheter structural heart procedures. Here are a few examples of how the newest technology is addressing these trends.


With the addition of its third 3D mammography system in early 2014, the University of Colorado Hospital established 3D as the standard of care in its breast imaging department. Located in Aurora, Colo., the hospital currently provides mammograms in two centers in the Denver area, and on its “Pink Lifesaver” mammography coach, which covers surrounding communities. The transition to 3D got a jump-start from fundraising efforts by the hospital’s “Men for the Cure” foundation, with donations from the group used to purchase the first 3D system and the mobile coach.  

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) recently held its annual meeting in St. Louis. It provided an in-depth review of molecular imaging technologies, clinical applications, and translational and advanced research topics for molecular imaging professionals — nuclear medicine physicians, scientists, radiologists, cardiologists, pharmacists, technologists, researchers, and others involved and interested in nuclear medicine and molecular imaging and therapy.


Fujifilm Medical Systems U.S.A. Inc. announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) of the Aspire Cristalle.

 

Siemens Healthcare recently submitted its premarket approval application (PMA) for the Mammomat Inspiration with Breast Tomosynthesis option to the U.S. Food and Drug Administration (FDA)


Breast cancer is a disease usually associated with women, as reflected by pink ribbons and gear, but men get it too, albeit rarely.


Subscribe Now